Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Invested Capital: 2009-2025

Historic Invested Capital for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $2.8 billion.

  • Prestige Consumer Healthcare's Invested Capital rose 1.25% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 1.25%. This contributed to the annual value of $2.8 billion for FY2025, which is 1.67% up from last year.
  • As of FY2025, Prestige Consumer Healthcare's Invested Capital stood at $2.8 billion, which was up 1.67% from $2.8 billion recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Invested Capital high stood at $3.1 billion for FY2022, and its period low was $2.8 billion during FY2024.
  • In the last 3 years, Prestige Consumer Healthcare's Invested Capital had a median value of $2.8 billion in 2023 and averaged $2.8 billion.
  • In the last 5 years, Prestige Consumer Healthcare's Invested Capital rose by 7.62% in 2022 and then decreased by 8.56% in 2023.
  • Prestige Consumer Healthcare's Invested Capital (Yearly) stood at $2.8 billion in 2021, then climbed by 7.62% to $3.1 billion in 2022, then fell by 8.56% to $2.8 billion in 2023, then declined by 0.43% to $2.8 billion in 2024, then grew by 1.67% to $2.8 billion in 2025.